Dewey McLin

Chief Tech/Sci/R&D Officer bei LONGBOARD PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profil

Dewey McLin is currently the Vice President & Head-Medical Affairs at Longboard Pharmaceuticals, Inc. Previously, he worked as the Senior Director-Medical Affairs at Greenwich Biosciences, Inc. and as the Vice President-Medical Affairs at Sesen Bio, Inc. for a brief period in 2021.
Dr. McLin completed his undergraduate degree at Indiana University and his doctorate at the University of California, Irvine.

Aktive Positionen von Dewey McLin

Unternehmen	Position	Beginn
LONGBOARD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	-

Alle aktiven Positionen von Dewey McLin

Ehemalige bekannte Positionen von Dewey McLin

Unternehmen	Position	Ende
CARISMA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01.09.2021
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Chief Tech/Sci/R&D Officer	-

Sehen Sie sich die Erfahrung von Dewey McLin im Detail an

Ausbildung von Dewey McLin

Indiana University	Undergraduate Degree
University of California, Irvine	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Dewey McLin im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
LONGBOARD PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Sesen Bio, Inc. Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.	Health Technology
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Health Technology